BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Saccharomyces cerevisiae var boulardii {S. boulardii} - Hydrogenophilia |
👶
Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury. Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 1359 Pub: 2017 May 2 Epub: 2017 May 2 Authors Yu L , Zhao XK , Cheng ML , Yang GZ , Wang B , Liu HJ , Hu YX , Zhu LL , Zhang S , Xiao ZW , Liu YM , Zhang BF , Mu M , Html Article Publication |
| Saccharomyces cerevisiae var boulardii {S. boulardii} - Hydrogenophilia |
👶
Effect of Saccharomyces boulardii and Bacillus subtilis B10 on gut microbiota modulation in broilers. Animal nutrition (Zhongguo xu mu shou yi xue hui) (Anim Nutr ) Vol: 4 Issue 4 Pages: 358-366 Pub: 2018 Dec Epub: 2018 Apr 3 Authors Qin C , Gong L , Zhang X , Wang Y , Wang Y , Wang B , Li Y , Li W , Html Article Publication |
| Saccharomyces cerevisiae var boulardii {S. boulardii} - Hydrogenophilia |
👶
Saccharomyces boulardii Tht 500101 changes gut microbiota and ameliorates hyperglycaemia, dyslipidaemia, and liver inflammation in streptozotocin-diabetic mice. Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 901-912 Pub: 2019 Dec 9 Epub: 2019 Dec 4 Authors Albuquerque RCMF , Brandão ABP , De Abreu ICME , Ferreira FG , Santos LB , Moreira LN , Taddei CR , Aimbire F , Cunha TS , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
